5AM’s Managerial Partner, Scott Rocklage

Scott Rocklage is often referred to as an example of the ambitious people. It was in the year 2003 that he made a significant step by considering it wise to join the 5AM Ventures. Despite having joined as a mere partner, he was promoted in one year. The elevation took place in the year 2004, and he turned out to be the managing director. Learn more about Scott Rocklage:  http://5amventures.com/team/scott-m-rocklage-phd/

As at now, he is a very experienced doctor alongside healthcare management. He has been giving service in the field for a lengthy period exceeding thirty years. With time, he has acquired himself a lot of leadership qualities and has tactical planning skills which that enhanced the approval of the US New Drug by FDA.

Scott Rocklage has also served as an outstanding leader in the position of the Chairman as well as that of the CEO at Cubist Pharmaceuticals. He also served in the same capacities at Nycomed Salutar. Before this, he occupied the position the Executive Chairperson at Ilypsa and gave support regarding the triumph of Semprus, and Miikana.

He attended the University of California, Berkeley where he attained his Bachelor of Science Degree in Chemistry. This achievement happened before his attainment of Ph.D. from the MIT where he pursued Chemistry as well. Scott Rocklage has carried out research in a research laboratory under the ownership of Richard R Schrock.

The latter is won the Nobel Prize in Chemistry in the year 2005. He is prominence is behind his innovation as the co-invention for more than thirty patents of the United States. He has also done reviews of publications exceeding a hundred. Boston is the base of his offices.

Anytime he attends interviews, he is frank and confidently talks about his life as well as the way he operates to ensure that he gains success in his endeavors from time to time. According to him, it is his routine to spend a day in search of new scientific ideas and in some occasions work with the portfolio while managing the firm. Read more: Scott Racklage | Bloomberg

Additionally, enjoys dealing with medical research that has the potential of serving the problems related to cancer. He intends to save lives and give a long lasting solution to the existing medical conditions.